Sur vs United Arab Emirates: HIV-positive TB patients on ART (antiretroviral therapy)
Sur
82.0%
in 2024
United Arab Emirates
100.0%
in 2024
Sur rank
2nd
United Arab Emirates rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Sur
- United Arab Emirates
How they compare
United Arab Emirates currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes United Arab Emirates's figure about 1.2 times Sur's.
The two have swapped places 2 times across 13 shared years of data; in 2010 it was United Arab Emirates ahead.
Sur ranks 2nd and United Arab Emirates ranks 1st of 2 regions.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sur | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.0% | 87.5% | 25.5% | United Arab Emirates |
| 2020s | 75.8% | 100.0% | 24.2% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Sur or United Arab Emirates?
- United Arab Emirates, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Sur and United Arab Emirates?
- 18.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for Sur and United Arab Emirates?
- 13 years are reported by both, from 2010 to 2024.
- How do Sur and United Arab Emirates rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Sur ranks 2nd and United Arab Emirates ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.